Lifevantage Corporation Common Stock (Delaware)

LFVNNASDAQ • USD
5.76 USD
↘ 0.11 (1.87%)AT CLOSE (03:59 PM EST)
5.74
↘ 0.02 (0.35%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
5.74
↘ 0.02 (0.35%)
🔴Market: CLOSED

Lifevantage Corporation Common Stock (Delaware) (LFVN) trades at $5.79 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 3, 2026.

Open?$5.86
High?$5.91
Low?$5.75
Prev. Close?$5.87
Volume?28.3K
Avg. Volume?28.5K
VWAP?$5.81
Rel. Volume?0.99x
Bid / Ask
Bid?$5.76 × 100
Ask?$6.20 × 700
Spread?$0.44
Midpoint?$5.98
Valuation & Ratios
Market Cap?73.9M
Shares Out?12.6M
Float?10.2M
Float %?81.4%
P/E Ratio?14.57
P/B Ratio?2.20
EPS?$0.40
Dividend?3.17%
Ex-Dividend?N/A
News
Profile
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
Employees
223
Market Cap
73.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1997-03-10
Address
3300 TRIUMPH BLVD
LEHI, UT 84043
Phone: 801-432-9000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
66
Momentum?
21
Short Sent.?
53
Piotroski F-Score?3/9Weak
Altman Z-Score?2.84Grey
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.54%Elevated
Short Interest?976.1K
Days to Cover?28.8
Free Float10.2M
Avg Daily Volume33.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.89Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.74Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
82
14.6CHEAP▾
P/B?
Peers
100
S&P
70
2.20CHEAP▾
P/S?
Peers
100
S&P
97
0.40CHEAP▾
P/FCF?
Peers
100
S&P
86
11.1CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
6.7CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.32CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
54
15.1%STRONG▾
ROA?
Peers
50
S&P
67
8.2%STRONG▾
Cash Flow & Enterprise
FCF?$6.7M
Enterprise Value?$59.0M
Fundamentals ratios updated end of day